Gaingels

Activity in this selectionBiotech

By stage

Series A2

Series C+1

Biotech3

United States3

3 in this selection

May 6

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A

Role not disclosed

May 4

Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2

$97MSeries A

Role not disclosed

Apr 15

Provides AI-powered platforms and integrated services for drug discovery and development

$40MSeries E

Role not disclosed